A meta-analysis investigating the efficacy and adverse events linked to sacubitril-valsartan in various heart failure subtypes.

Authors:
Ji Q.

Journal:
Clin Cardiol

Publication Year: 2023

DOI:
10.1002/clc.24192

PMCID:
PMC10823544

PMID:
38013641

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Clin Cardiol

Abbreviation: Clin Cardiol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Cardiology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A novel contact force sensing pulsed field ablation catheter in a porcine model.
Hua J; Xiong Q; Kong Q and 8 more (2024) - Transparency Score: 3/6
A systematic review of present and future pharmaco-structural therapies for hypertrophic cardiomyop…
Sawan MA; Prabakaran S; D'Souza M and 4 more (2024) - Transparency Score: 2/6
Clinical characteristics and statin eligibility of patients under 50 with ST-elevation myocardial i…
Haq A; Walser-Kuntz E; Gamam A and 4 more (2024) - Transparency Score: 2/6
Contractility, ventriculoarterial coupling, and stroke work after acute myocardial infarction using…
Nordlund D; Lav T; Jablonowski R and 6 more (2024) - Transparency Score: 3/6
Correlation between the serum FABP4, ANGPTL3, and ANGPTL4 levels and coronary artery disease.
Zhao Z; Fu Y; Lian H and 4 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST STATEMENT The authors declare no conflict of interest."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025